Search

everythinglearnresearchcommunity

for

Search:↓

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

People with Down syndrome often have skin issues and need regular check-ups for early treatment.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

The document concludes that doctors should carefully consider off-label drug use in dermatology and always inform patients, while more research is needed on the safety and effectiveness of such practices.

Effective symptom management in IBD improves quality of life and prevents complications.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Increased HIF-1α is linked to the inflammation and severity of hidradenitis suppurativa, suggesting treatments that lower HIF-1α could help.

Sorafenib can cause delayed skin problems, so patients need careful monitoring.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

An elderly man's hair grew back after treatment with secukinumab, possibly due to reduced scalp inflammation or the medication's direct effects.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Dermatological diseases affect women's work performance more than men's.

Gray hair can potentially be reversed, leading to new treatments.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.

TNF-alpha inhibitors can cause various immune-related skin issues.

The Facial Psoriasis Log-based Area and Severity Index is a more effective way to measure improvements in facial psoriasis than the traditional method.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

Certain drugs may cause vitiligo, so patients should be monitored.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

New treatments for severe alopecia areata show promise but lack standard approval.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

The research showed that CRISPR/Cas9 can fix mutations causing a skin disease in stem cells, which then improved skin grafts in mice, but more work on safety and efficiency is needed.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Finasteride for hair loss in young men may significantly increase the risk of sexual dysfunction.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.